SEC Form 4 · accession 0001209191-17-017122
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francis Willard Sarena
Officer — Chief Strategy Officer
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 1:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2017 | F | 19,784 | $44.77 | D | 75,118 | D |
Table II — derivative securities
No Table II lines on this filing.